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Abstract
Background: While occipital periventricular hyperintensities (OPVHs) are among the most common mild white matter
hyperintensities, the clinical factors associated with OPVHs remain unclear. In this study, we investigated the role of
clinical factors in development of pure OPVHs.
Methods: This study included 97 patients with OPVHs and 73 healthy controls. Univariate analysis of clinical factors in
OPVH patients and controls was followed by binomial logistic regression analysis to identify clinical factors significantly
associated with OPVHs.
Result: Univariate analysis indicated that age, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and
apolipoprotein-B (Apo-B) levels differed significantly between the OPVH patients and controls (p < 0.05). Age and
gender were correlated with OPVH scores (p < 0.05), while LDL-C, triglycerides, Apo-B and TC were anti-correlated with
OPVHs scores (p < 0.05). Multivariate analysis indicated that LDL-C is negatively correlated with OPVHs (p < 0.05), and
age is positively correlated with OPVHs (p < 0.001).
Conclusion: In summary, LDL-C was negatively and age was positively associated with OPVHs among Chinese patients
in a hospital.
Keywords: MRI, White matter hyperintensity, Occipital periventricular hyperintensities, Low-density lipoprotein
cholesterol, Cardiovascular risk factor
Background
White matter hyperintensities (WMHs), which reflect
chronic vascular ischemic diseases, may only represent
extreme cases of white matter injury [1]. Previous stud-
ies have investigated WMH progression and its clinical
significance [2]. However, the optimal treatment regimen
remains to be elucidated [3]. WMH can be categorized
as periventricular hyperintensities (PVHs) or deep white
matter hyperintensities (DWMHs) [4]. As the severity of
the lesions increase, PVHs can extend into the deep
white matter (DWM) and may subsequently develop
into confluence DWMHs [5]. The precise differences
between PVHs and DWMHs have not yet been fully ex-
plored, though some studies have suggested that their
clinical and pathological features differ [6]. PVHs have
also been suggested to be associated with brain atrophy,
while DWMH is related to cerebrovascular events [7].
PVHs typically have caps around the occipital or frontal
horns of the lateral ventricles and a pencil-thin lining or
a smooth halo along the side of the lateral ventricles [8].
Thus, WMHs is often parcellated based on anatomy,
such as occipital, parietal, frontal, and temporal lobes, as
well as in fratentorial and basal ganglia regions, to assess
its impact [9]. Such classifications can also reflect the
different pathophysiological mechanisms of WMHs, and
may be used to inform the design of clinical interventions.
In addition, clarifying differences between PVHs and
DWMHs may provide insights in the clinical significance
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of WMHs, and differences between pathological aging
and normal aging.
Previous studies have reported that age and hyperten-
sion are common risk factors for WMHs [10, 11]. In con-
trast, the results of studies implicating other potential risk
factors associated with WMH, such as diabetes mellitus,
hyperlipidemia, smoking, high body mass index, vitamin
B12 deficiency, and alcohol consumption, were inconsist-
ent [10, 12–17]. Some studies have reported that hyperlip-
idemia has a protective effect on WMHs, however, these
studies included mixed lesions which did not differentiate
between early or mild lesions [18]. To our knowledge, the
clinical factors contributing to WMHs at a single site have
not yet been addressed. With reference to the aforemen-
tioned studies, we hypothesized that age is a risk factor
while lipids and/or lipoproteins could have a protective ef-
fect on WMHs. In this case–control study, we investigated
the role of clinical factors in development of pure OPVHs
at a single site.
Methods
Subjects
Head magnetic resonance imaging (MRI) images were
obtained in a total of 170 subjects from the department
of neurology in Xinqiao Hospital, Third Military Medical
University (age range: 55–85 years old). Images with
Occipital periventricular hyperintensities (OPVHs) were
identified according to the inclusion exclusion criteria.
Their respective clinical data were then collected, and
the patients were examined. The subjects were restricted
from vitamin B12 intake for 3 months prior to scanning.
Subjects with other diseases that can cause white matter
lesions, such as toxic cerebral white matter lesions, mul-
tiple sclerosis, atrial fibrillation, progressive multifocal
leukoencephalopathy and thyroid disease, were excluded
from the study. In addition, we also excluded patients
with cerebrovascular disease induced by heart and aorta
embolism, atrial fibrillation, valvulopathy, myocardiopa-
thy, endocarditis, left atrioventricular valve stenosis or
ventricular aneurysm, vasculitis, familial high homocyst-
eine, infectious diseases, anemia or malignant disease,
intracranial tumors, systemic diseases, immune system
diseases such as connective tissue or autoimmunity dis-
eases, and those receiving treatments such as radiother-
apy, drug chemotherapy and biological therapy.
Subjects were classified into two groups, OPVHs group
(n = 97 with OPVHs ≥ 1 and without lesions in other loca-
tions) and control group (n = 73 with no WMHs) according
to the Fazekas scale. No subjects had cerebral infarcts, de-
fined as focal hyperintensities in T2 images. The gender
(Gen), age, hypertension (Htn) and history of diabetes mel-
litus (DM), current smoking (CS) and alcohol use (CAU)
were obtained with a patient-administered questionnaire.
Total cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C),
triglycerides (TG), uric acid (UA), apolipoprotein-A1 (Apo-
A1) and apolipoprotein-B (Apo-B) were also obtained. Note
that this is a retrospective study, and the MRI images were
obtained between 2012 October and 2015 October.
MRI protocols
All MRI data were obtained using a 3.0 Tesla scanner
(General Electric, Milwaukee, WI, USA) with a 12-channel
head coil. FSE T2-weighted images and FLAIRT1-weighted
images were acquired with TE/TR =112.2/3160 ms and
TE/IT/TR =27.072/860/1696.68 ms, respectively. All MRI
images were acquired with voxel size of 0.4688 × 0.4688 ×
5 mm3, 20 sagittal slices and an in-plane resolution of
512 × 512. MRI images were then assessed visually by two
neurologist using the Fazekas scale [19].
Data analysis
Demographic and clinical variables were statistically ana-
lyzed using SPSS20 (IBMSPSS, Chicago, USA). Data are
presented as mean and standard deviation. Chi-square
test and student’s t-test were used to determine signifi-
cant differences between frequencies of categories and
continuous variables of the groups. In addition, the rela-
tionship between these factors and OPVH scores were
analyzed using bivariate Pearson Correlation analysis.
Subsequently, binomial logistic regression analysis and
likelihood ratio test were performed to identify factors
independently associated with OPVHs. To access and
compare the sensitivity and specificity of using age and
LDL-C as diagnostic factors, the receiver operating char-
acteristic (ROC) curve was plotted using OPVHs as
positive outcome, and age and LDL-C as diagnostic fac-
tors. Subsequently, the Youden Indices were calculated
and the maximum Youden Index was used as cut-off
value in the ROC curve [20–22]. The cut-off values for
age and LDL-C were 57 years and 2.645 mmol/L, re-
spectively. Using these cut-off values, the sensitivity and
specificity were obtained. Finally, the area under ROC
curve was quantified and statistically analyzed using
SPSS. Results were considered significant when P < 0.05.
Results
T2-weighted MRI changes in OPVH patients
Figure 1 shows two typical T2-weighted MRI images of a
control (Fig. 1a) and a OPVHs patient (Fig. 1b). High-
signal intensities were observed on the T2-weighted im-
ages of OPVHs patients. In addition, no cerebral infarcts
were observed on the T2-weighted images in all subjects.
Clinical variables and OPVHs using univariate analysis
Table 1 summarizes the differences between the
OPVH patients and controls. The OPVH patients were
significantly older (p < 0.001), with lower TC (p <0.05),
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LDL-C (p < 0.001) and Apo-B (p < 0.05) levels. Table 2
summarizes the correlations between OPVHs and poten-
tial risk factors. Spearman correlation analysis indicated
that age (p < 0.001) and gender (p < 0.05) were correlated
with OPVHs, while LDL-C (p < 0.001), TG (p < 0.05),
Apo-B (p < 0.001) and TC (p < 0.05) were anti-correlated
with OPVHs.
Clinical variables and OPVHs using multivariate analysis
Binomial logistic regression analysis indicated that age
(p < 0.001) was positively correlated with OPVHs, while
LDL-C (p < 0.05) was negatively correlated with OPVHs
(Table 3). For ROC analysis, the sensitivity and specifi-
city of age as a diagnostic factor were 0.986 and 0.041,
respectively. On the other hand, the sensitivity and
specificity of LDL-C as a diagnostic factor were 0.630
and 0.639, respectively. The ROC indicated that age
(p < 0.001) and LDL-C (p < 0.01) differed significantly
between OPVH patients and healthy controls (Table 4).
These results suggest that OPVHs and age are positively
associated, while OPVHs and LDL-C are negatively asso-
ciated, respectively. It should be noted that LDL-C was a
better predictor of OPVHs than age, based on the area
under the curve (Fig. 2).
Fig. 1 Typical T2-weighted MRI images a control and a OPVHs patient. Two typical T2-weighted MRI images of a control (a) and a OPVHs patient
(b). High-signal intensities are observed on the T2-weighted image of the OPVHs patient. In addition, no cerebral infarcts were observed on the
T2-weighted images in any subjects
Table 1 Clinical factors differing between OPVHs and CN
Group OPVHs CN χ2/t p
n 97.00 73.00 / /
OPVH Scores 2.72 (0.54) 0.00 (0.00) / /
Gen (n,% male)1 61(62.89) 35(47.95) 3.78 0.05
Age (years)2 71.79(8.29) 68.9(7.91) −4.87 <0.001*
CS (n,%)1 24(24.74) 21(28.77) 0.35 0.56
CAU (n,%)1 21(21.65) 14(19.18) 0.16 0.69
Htn (n,%)1 47(48.45) 26(35.62) 2.80 0.09
DM (n,%)1 18(18.56) 8(10.96) 1.86 0.17
TC2 4.61(1.07) 4.81(0.96) 2.05 0.04*
TG2 1.44(0.76) 1.66(1.17) 1.48 0.14
LDL_C2 2.51(0.63) 2.83(0.68) 3.20 <0.001*
HDL_C2 1.34(0.32) 1.29(0.30) −0.95 0.34
UA2 289(75.30) 277.75(67.33) −1.01 0.31
Apo-A12 1.30(0.31) 1.25(0.33) −1.01 0.31
Apo-B2 0.84(0.24) 0.91(0.23) 2.24 0.03*
Continuous variables are presented as mean (standard deviation) and
compared using Student’s t-test, while categorical variables are presented as
percent and compared between groups using the chi-square test,. 1, 2 * denotes
Chi-square test, Student’s t-test and p < 0.05, respectively
Table 2 Correlation of clinical factors and OPVHs














Statistical correlations were determined by two-tailed bivariate Pearson correlation
coefficient test with all risk factors as independent variables and the OPVH scores as
dependent variables. * denotes p< 0.05
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Discussion
White matter hyperintensities (WMHs) are thought to
reflect chronic cerebral small vessel diseases, and can be
easily detected using MRI. In previous studies, age and
hypertension were reported to be the most common risk
factors for WMHs [10, 11], while the role of other po-
tential risk factors, such as diabetes mellitus, hyperlipid-
emia, smoking, high body mass index, B12 deficiency,
and alcohol were reported inconsistently [10, 12–17].
Our results demonstrate that age was strongly correlated
with the occurrence of OPVHs, which is consistent with
previous studies. In addition, LDL-C was anti-correlated
with OPVHs. These results indicate that age was posi-
tively correlated to OPVHs, while LDL-C was negatively
correlated with OPVHs.
Receiver operating characteristic curve (ROC), also
known as susceptibility curve, sensitivity curve, or diag-
nostic curve, can reflect both sensitivity and specificity.
The ROC curve is based on the probability of true posi-
tive rate versus false positive rate. Note that the closer
the ROC curve is to the upper left, the higher the accur-
acy of the test. In other words, the point of the ROC
curve closest to the upper left corner is the best thresh-
old to be used with a minimal number of false positives
and false negatives. The advantages of ROC curve are as
follows. First, it can easily identify the diagnostic ability
using an optimal diagnostic threshold. Second, ROC
curve can differentiate two or more different diagnostic
tests by plotting the ROC curves of each trial or diag-
nostic test in the same plot to visually identify the ad-
vantages and disadvantages of these diagnoses. Third, it
is possible to compare the area under the ROC curve
(AUC) for each method, which the larger that AUC the
better, to identify the best diagnostic method [21, 23]. In
order to study the sensitivity and specificity of LDL-C in
diagnosing OPVHs, we performed ROC curve analysis.
Our results indicate that LDL-C was a better predictor
of OPVHs than age, since the sum of sensitivity and spe-
cificity of LDL-C is higher than that of age. Despite the
advantages of ROC curve analysis, it should be noted
that high AUC values may actually have poor overall ac-
curacy in some cases.
LDL-C is widely recognized as a risk factor for stroke
[24, 25], and lipid-lowering therapies have demonstrated
benefits in stroke prevention and prognosis [26, 27]. Sta-
tin treatment may protect the vessels of the brain and
increase survival rate. However, previous studies have sug-
gested that statin treatment may deteriorate WMHs [28].
We observed that higher LDL-C levels were associated
with lower severity of OPVHs, which is consistent with
previous findings [29, 30]. Our results also highlighted
other less influential factors, with LDL-C being a more in-
fluential factor than age. Although the mechanisms under-
lying the anti-correlation between LDL-C and OPVHs are
not fully understood, we speculate that cholesterol may
play an important role in neuron repair and remodeling in
the central nervous system [31].
Previous studies of the effect of pravastatin on the pro-
gression of ischemic brain lesions were evaluated using
MRI longitudinally [32]. After treatment, no difference in
lesion progression was observed between the pravastatin-
treated and placebo groups. In another study involving
participants with long-standing type 2 diabetes at a high
risk for cardiovascular events, decreased LDL-C levels did
not produce significant cognitive changes at 40 months of
follow-up [33]. These studies suggest that lowering choles-
terol did not benefit the white matter or cognitive func-
tions. However, our results suggest that decreasing LDL-C
could deteriorate WMHs. It should be noted that our
study focused on mild OPVHs, while previous studies in-
cluded more severe OPVHs. This might explain the dis-
crepancy between our results and those of previous
studies, since early mild lesions should have less influence
factors. Our study also provides insights that may inform
development of simple preventive measures.
WMHs are largely divided into PVHs and deep
DWMHs [4], but the precise difference between PVHs
and DWMHs is yet to be fully elucidated, with both
types strongly associated with age [34]. Previous studies
have suggested that the clinical and pathological features
of these two types of WMHs are diverse [6]. PVHs may
be more strongly affected by additional factors related to
aging, such as hypotension, hypoperfusion, and atrophy
[35–37], whereas DWMHs may be associated with cere-
brovascular events [7]. Previous studies indicate that a




B p-value OR 95% C. I. of OR
Lower Bound Up Bound
Age 0.09 <0.001* 1.09 1.04 1.14
Gen 0.53 0.16 1.70 0.82 3.52
TC 0.43 0.26 1.53 0.73 3.20
TG −0.18 0.33 0.84 0.59 1.20
LDL-C −0.99 0.03* 0.37 0.16 0.89
Apo-B −0.17 0.86 0.84 0.13 5.55
P-values were obtained using OPVHs as positive outcome and Age, Gen, TC,
TG, LDL-C, Apo-B as independent variables by binomial Logistic regression
analysis. * denotes p < 0.05
Table 4 Diagnostic strength of independent factors for OPVHs
Variable Area p-value 95% C. I. of Area
Lower Bound Upper Bound
Age 0.290 <0.001* 0.211 0.368
LDL-C 0.642 0.002* 0.558 0.726
P-values and the area under the curve were obtained using OPVHs as positive
outcome with age and LDL-C as diagnostic factor. * denotes p < 0.05
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reduction in total cerebral blood flow is associated with
increased PVH volume but not DWMH volume [38]. It
is also known that cholesterol can play a fundamental
role in the development of the central nervous system
and in the creation and maintenance of new synapses,
which may be related to OPVHs [31, 39, 40]. Hypoperfu-
sion may reduce delivery of nutrients to the white mat-
ter in the brain [41]. The periventricular white matter
extends 3 to 13 mm around the periventricle [42], the
blood supply of this area is provided by choroidal arter-
ies or the terminal branch of lenticulostriate arteries of
subependymal artery [43], anastomose of the vessels is
sparse or missing, and the area is prone to ischemia dur-
ing cerebral ischemia or hypoperfusion [41]. Surpris-
ingly, accumulating evidence suggests that it is low
rather than high levels of circulating cholesterol that
may contribute to the risk of primary intracerebral
hemorrhage [44] and to a higher mortality rate in these
patients [45]. Furthermore, it has been shown that
higher cholesterol levels are associated with less severe
WMHs [46–48]. This could explain the role of elevated
cholesterol levels and a better response to an acute in-
jury such as stroke, as well as better responses to
chronic cerebral injury (such as the processes involved
in WMH development). Our results, along with these
previous studies, support the hypothesis that hyperchol-
esterolemia may play a protective role in cerebral small-
vessel disease [49], whereas hypocholesterolemia appears
to impair endothelial reparative processes [50]. Both lower
LDL-C and severity of WMH have a significant heritability
component [51, 52]. Combined with previous research,
our results show that higher cholesterol was associated
with reduced OPVHs, and relatively higher cholesterol
might be associated with better health status in late life
[53]. It should be noted that abnormally high cholesterol
levels are not associated with better health. Our study pro-
vides a basis for the selection of populations that require
intervention and intervention methods, in particular the
widespread use of statins should be carefully reviewed.
Our results also offer a model for the investigation of
WMH pathogenesis in future animal studies.
The limitations of this study relate first to its retro-
spective design, and second to the small sample size. A
specifically designed, randomized, controlled prospective
population-based study may ultimately clarify the role of
LDL-C in OPVHs, and is warranted in future studies.
Our ROC analysis revealed that using age as the diag-
nostic factor of OPVHs was mathematically correct,
however, it may have few implications as the results
showed a low specificity. Future studies may investigate
Fig. 2 Receiver operating characteristic curve using age and LDL-C as diagnostic factors for OPVHs. ROC were obtained using OPVHs as positive
outcome and age and LDL-C as diagnostic factors. It should be noted that the diagnostic strength of LDL-C, calculated using on the area under
the curve, was greater than that of age for OPVHs
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other parameters as diagnostic factors of OPVHs. Also,
our findings are only from a Chinese hospital and do
not rule out the possibility of selective bias or sampling
error. In addition, future studies may encompass the
mechanisms on how LDL-C affects OPVHs using animal
models. Although body mass index and VB12 are associ-
ated with OPVHs, how these factors exactly affect
OPVHs remains to be elucidated.
Conclusions
LDL-C was negatively, and age was positively associated
with OPVHs among Chinese patients in a hospital.
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